Literature DB >> 13482230

Outpatient P.A.S. therapy.

W M DIXON, P STRADLING, I D WOOTTON.   

Abstract

Entities:  

Keywords:  TUBERCULOSIS/therapy

Mesh:

Year:  1957        PMID: 13482230     DOI: 10.1016/s0140-6736(57)90006-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  30 in total

1.  PROLONGED STREPTOMYCIN AND ISONIAZID FOR PULMONARY TUBERCULOSIS.

Authors:  R N JOHNSTON; D H SMITH; R T RITCHIE; W LOCKHART
Journal:  Br Med J       Date:  1964-06-27

2.  An assessment of antibacterial treatment used alone or in association with surgical operation in the treatment of pulmonary tuberculosis.

Authors:  J R EDGE; W H HELM; M R GEAKE; R L WARD
Journal:  Thorax       Date:  1961-09       Impact factor: 9.139

3.  Simplification of the ferric chloride test for P.A.S. in urine.

Authors:  P P TURNER
Journal:  Br Med J       Date:  1959-06-13

4.  Plasma pempidine concentrations in hypertensives.

Authors:  C T DOLLERY; D EMSLIE-SMITH; D F MUGGLETON
Journal:  Br Med J       Date:  1960-02-20

5.  Resection for pulmonary tuberculosis.

Authors:  J R EDGE; D E BOTTRILL
Journal:  Br Med J       Date:  1959-01-31

6.  Chemotherapeutic pitfalls in the treatment of tuberculosis.

Authors:  G POOLE; P STRADLING
Journal:  Br Med J       Date:  1960-01-16

7.  New stick test for P.A.S. in urine. Report on use of "phenistix" and problems of long-term chemotherapy for tuberculosis.

Authors:  G R LUNTZ; R AUSTIN
Journal:  Br Med J       Date:  1960-06-04

8.  Tranquillizers.

Authors:  M Weatherall
Journal:  Br Med J       Date:  1962-05-05

9.  Behavioral engineering: the use of response priming to improve prescribed self-medication.

Authors:  N H Azrin; J Powell
Journal:  J Appl Behav Anal       Date:  1969

Review 10.  What's in a name? Medication terms: what they mean and when to use them.

Authors:  Nicholas Wride; Tracy Finch; Tim Rapley; Tiago Moreira; Carl May; Scott Fraser
Journal:  Br J Ophthalmol       Date:  2007-11       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.